Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis

A wide range of rare diseases can have fiscal impacts on government finances that extend beyond expected healthcare costs. Conditions preventing people from achieving national lifetime work averages will influ...

Source: Orphanet Journal of Rare Diseases - September 18, 2019 Category: Internal Medicine Authors: Mark P. Connolly, Saswat Panda, Julien Patris and Bouke P. C. Hazenberg Tags: Research Source Type: research